These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20109825)

  • 1. Budesonide and risk of pneumonia.
    Black PN; Sexton PM
    Lancet; 2009 Dec; 374(9707):2050-2051. PubMed ID: 20109825
    [No Abstract]   [Full Text] [Related]  

  • 2. Budesonide and risk of pneumonia.
    Kramer AB; Gans RO
    Lancet; 2009 Dec; 374(9707):2051. PubMed ID: 20109828
    [No Abstract]   [Full Text] [Related]  

  • 3. Budesonide and risk of pneumonia.
    Singanayagam A; Chalmers JD
    Lancet; 2009 Dec; 374(9707):2050. PubMed ID: 20109824
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies.
    Hollis S; Jorup C; Lythgoe D; Martensson G; Regnell P; Eckerwall G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1071-1084. PubMed ID: 28435240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
    O'Byrne PM; Pedersen S; Carlsson LG; Radner F; Thorén A; Peterson S; Ernst P; Suissa S
    Am J Respir Crit Care Med; 2011 Mar; 183(5):589-95. PubMed ID: 20889908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide and the risk of pneumonia: a meta-analysis of individual patient data.
    Sin DD; Tashkin D; Zhang X; Radner F; Sjöbring U; Thorén A; Calverley PM; Rennard SI
    Lancet; 2009 Aug; 374(9691):712-9. PubMed ID: 19716963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
    Thorsson L; Geller D
    Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung deposition of inhaled drugs increases with age?
    Amirav I; Newhouse MT
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1279. PubMed ID: 11316672
    [No Abstract]   [Full Text] [Related]  

  • 9. Budesonide turbuhaler for asthma.
    Med Lett Drugs Ther; 1998 Jan; 40(1018):15-6. PubMed ID: 9457158
    [No Abstract]   [Full Text] [Related]  

  • 10. Budesonide/formoterol in the treatment of asthma.
    Hodgson D; Mortimer K; Harrison T
    Expert Rev Respir Med; 2010 Oct; 4(5):557-66. PubMed ID: 20923335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of budesonide plus formoterol (BF) Spiromax® and BF Turbohaler® (with and without charcoal block) in healthy volunteers.
    Weisfeld L; Shu Y; Shah TP
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):593-602. PubMed ID: 26042485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
    Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin atrophy caused by inhaled steroids?].
    Konietzko N
    Dtsch Med Wochenschr; 1999 Jul; 124(28-29):882-3. PubMed ID: 10432953
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler.
    Chrystyn H; Safioti G; Keegstra JR; Gopalan G
    Int J Pharm; 2015 Aug; 491(1-2):268-76. PubMed ID: 26043823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma.
    Shrewsbury SB; Bosco AP; Uster PS
    Int J Pharm; 2009 Jan; 365(1-2):12-7. PubMed ID: 18786624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Jun; 161(6):2114-5. PubMed ID: 10852798
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral posterior subcapsular cataracts after inhaled budesonide for asthma: have patients been given their medications correctly?
    Guner SN; Kilic M; Boyraz S; Yurdakul E; Kalkan G; Ozturk F
    J Investig Allergol Clin Immunol; 2011; 21(1):80. PubMed ID: 21370732
    [No Abstract]   [Full Text] [Related]  

  • 18. A contact allergic reaction to budesonide mimicking immediate-type allergy.
    Opstrup MS; Garvey LH; Johansen JD; Bregnbak DK; Thyssen JP
    Contact Dermatitis; 2017 Jul; 77(1):62-63. PubMed ID: 28612436
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic availability of Rhinocort Aqua (budesonide) nasal spray: importance of formulation and definition of delivered dose.
    O'Dowd L; Thorsson L; Edsbacker S
    J Allergy Clin Immunol; 2002 Jun; 109(6):1037; author reply 1037-8. PubMed ID: 12063539
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to: "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Letter].
    Barnes NC; Singh D; Lipson DA
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1299-1301. PubMed ID: 34007169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.